News

Innovation alliance unveils new name and strategic plan for Western Virginia

A strategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that stretches from Lynchburg to the New River Valley.

Formed last year, the alliance is a joint mission of the Valleys Innovation Council, the Roanoke-Blacksburg Technology Council and the Regional Accelerator and Mentoring Program, known as RAMP.

At a virtual news conference Monday, organizers said the unified strength of the three organizations will help solidify connections and better leverage emerging opportunities for the region’s technologists, innovators and entrepreneurs.

Verge will focus on the technology and life sciences innovation ecosystem in the GO Virginia Region 2, a sprawling span of the state that includes the Roanoke and New River valleys, the Alleghany Highlands and the Lynchburg region.

“What is happening in technology in this part of Virginia is really exciting,” CEO Greg Feldmann said in a statement.

“By aligning the efforts of three distinct but synergistic entities, we will all more effectively develop external resourcing, more efficiently implement new programs ensuring each reaches the right audiences at the right moments and in the right contexts to provide maximum value.

“It’s all about comprehensively supporting the many people and organizations who are investing in and shaping the economic future of our region.”

While collaborating in the newly defined joint mission, the three organizations will continue their day-to-day operations under the same leadership.

Recent News

07/22/2025

ReAlta Life Sciences Publishes Data Demonstrating RLS-0071 (pegtarazimod) Reduces Brain Inflammation in Preclinical Hypoxic Ischemic Encephalopathy Model

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced the publication of an article in the American Journal of Perinatology showing the ability of RLS-0071 (pegtarazimod) to reduce key measures of brain inflammation in

07/22/2025

InBio and Beckman Coulter Partner to Advance Food Allergy Diagnostics

InBio, a global leader in high-quality, purified allergen proteins, and Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, are collaborating to enhance the performance of basophil activation tests (BAT) for food allergy research. The collaboration integrates InBio’s Food Protein Standards and purified allergens with the Next-Generation Basophil

07/22/2025

Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased valuation from previous funding. The $37 million raise supports the Company’s mission of helping brilliant minds bring medicines to life through advanced development and manufacturing in America. The growing